Tianqin Mao

Moderately differentiated esophageal squamous cell carcinoma has a poor prognosis after neoadjuvant chemoradiotherapy

M. Scarpa, Wenwu He, Yongtao Han, 2021, Annals of translational medicine.

The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis

Wenwu He, Yongtao Han, X. Leng, 2021, Annals of translational medicine.

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Xudong Shen, Ting Bei, Wenwu He, 2022, The oncologist.

MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma

Hong Wu, Wenwu He, Yongtao Han, 2021, Frontiers in Oncology.

Impact of two‑field or three‑field lymphadenectomy on overall survival in middle and lower thoracic esophageal squamous cell carcinoma: A single‑center retrospective analysis

Wenwu He, Kun Liu, Lin Peng, 2023, Oncology letters.

Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell Carcinoma.

Tao Jiang, Feifei Li, Z. Xiao, 2023, Cancer Research.